From Fixed to Individual Dosing in Growth Hormone-Deficient Adults
- 1 January 2001
- journal article
- review article
- Published by S. Karger AG in Hormone Research in Paediatrics
- Vol. 56 (Suppl. 1) , 35-37
- https://doi.org/10.1159/000048132
Abstract
Initial research studies of growth hormone (GH) replacement in adults employed what is now considered to be high doses of GH, from 12 to 25 µg/kg per day. While the beneficial effects of GH were demonstrated, there was a considerable incidence of side effects, most commonly edema and arthralgia. These side effects abated with a dose reduction. More recently, the Growth Hormone Research Society recommended initiating GH replacement at a dose of 0.3 mg/day irrespective of total or ideal body weight. The United States Food and Drug Administration approved pharmaceutical company package inserts that recommended beginning with a dose of 6 µg/kg per day with a maximum dose of 25 µg/kg per day and limiting the maximal dose to 12.5 µg/kg per day in adults over the age of 35 years. These should be considered as guidelines.Keywords
This publication has 2 references indexed in Scilit:
- Continuation of Growth Hormone (GH) Replacement in GH-Deficient Patients during Transition from Childhood to Adulthood: A Two-Year Placebo-Controlled StudyJournal of Clinical Endocrinology & Metabolism, 2000
- Consensus Guidelines for the Diagnosis and Treatment of Adults with Growth Hormone Deficiency: Summary Statement of the Growth Hormone Research Society Workshop on Adult Growth Hormone DeficiencyJournal of Clinical Endocrinology & Metabolism, 1998